Proteolease Ltd.

About

Offices

Q&A

What is Proteolease Ltd. developing?

Proteolease Ltd. is developing an innovative product called X-Tract for atraumatic, fast healing, and stress-free tooth extraction. This product biologically degrades the filaments connecting the tooth root to the alveolar bone by enzymatically decomposing the periodontal ligament (PDL).

What problem does Proteolease's X-Tract product aim to solve?

The X-Tract product aims to simplify complicated surgical tooth extraction procedures by eliminating the need for uncontrolled mechanical distraction, tear, and release. This allows general dentists to perform multiple extractions without causing trauma to the patient and surrounding tissues, enabling fast recovery or immediate tooth restoration with a dental implant.

When was Proteolease Ltd. founded?

Proteolease Ltd. was founded in 2012.

Where is Proteolease Ltd. headquartered?

Proteolease Ltd. is headquartered in Ramat Hasharon, Israel.

Who are the co-founders of Proteolease Ltd.?

The co-founders of Proteolease Ltd. are Yossi Gafni, who also serves as Co-Founder & CTO, and Dr. Evgeny Weinberg.

What is Proteolease Ltd.'s primary sector?

Proteolease Ltd.'s primary sector is Healthcare, specifically focusing on Biotechnology and Medical Devices.

What core technology does Proteolease Ltd. utilize?

Proteolease Ltd. utilizes enzymatic degradation as its core technology for its dental system.

Who are the target customers for Proteolease Ltd.'s products?

The target customers for Proteolease Ltd.'s products are dentists and dental clinics.

Sectors & technology